Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cay, O.
Right arrow Articles by Clouse, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cay, O.
Right arrow Articles by Clouse, M. E.

Radiology, Vol 205, 95-101, Copyright © 1997 by Radiological Society of North America

ARTICLES

Liver metastases from colorectal cancer: drug delivery with liposome- encapsulated doxorubicin

O Cay, JB Kruskal, I Nasser, P Thomas and ME Clouse
Department of Radiological Sciences, Beth Israel Deaconess Medical Center, Boston MA, USA.

PURPOSE: To evaluate the intratumoral distribution of liposome- encapsulated doxorubicin. MATERIALS AND METHODS: Tumor-bearing livers of 24 mice were studied with in vivo fluorescence and electron microscopy after injection of liposomal doxorubicin in the hepatic artery, portal vein, or tail vein. Distribution and uptake of liposomes and doxorubicin in tumors were compared at 5, 30, and 60 minutes after injection. In vitro evaluation of uptake of doxorubicin in Kupffer cells and in human colorectal cancer cells incubated under normoxic and hypoxic conditions for 5, 30, and 60 minutes was performed with fluorescence microscopy. RESULTS: Doxorubicin autofluorescence was seen in tumors 30 minutes after intraarterial and intraportal injection and was statistically significantly greater at 60 minutes (P < .001). Liposomes were observed in small tumors (diameter < 300 microns) and were trapped in Kupffer cells around larger, hypovascular tumors. Electron microscopy findings confirmed intracytoplasmic, perinuclear uptake of liposomes in tumor cells. In vitro, a higher proportion of doxorubicin was seen in cancer cells (92%) than in Kupffer cells (75%) after 60 minutes incubation. CONCLUSION: Liposomal doxorubicin can be reliably delivered to liver metastases via the hepatic artery, eliminating need for tumor embolization. Further evaluation is warranted, and the drug may be useful for treating patients with unresectable liver metastases.


This article has been cited by other articles:


Home page
 RadiologyHome page
J. B. Kruskal, P. Thomas, R. A. Kane, and S. N. Goldberg
Hepatic Perfusion Changes in Mice Livers with Developing Colorectal Cancer Metastases
Radiology, May 1, 2004; 231(2): 482 - 490.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
J. B. Kruskal, P. Thomas, I. Nasser, O. Cay, and R. A. Kane
Hepatic Colon Cancer Metastases in Mice: Dynamic in Vivo Correlation with Hypoechoic Rims Visible at US
Radiology, June 1, 2000; 215(3): 852 - 857.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 1997 by the Radiological Society of North America.